Insili Intelligence (03696) and Kangzhe Pharmaceutical (00867) reached a new strategic cooperation for drug development in the field of central nervous system

Zhitongcaijing · 3d ago

Zhitong Finance App News, Insili Intelligence (03696) announced that the Group has reached a new strategic cooperation with Kangzhe Pharmaceutical Holdings Co., Ltd. (Kangzhe Pharmaceutical, stock code: 00867).

According to the terms of the cooperation agreement, the two sides will combine the proven AI platform of Insili Intelligence with AI to enable innovative drug research and development capabilities, as well as Kangzhe Pharmaceutical's experienced R&D team and deep understanding of the disease field to jointly promote the cooperative development of innovative drugs. Based on this partnership, British Silicon Intelligence is expected to receive a total milestone payment of up to RMB 1.2 billion, as well as a net sales share.